"The U.S. Food and Drug Administration announced today that injectable drugs used in total parenteral nutrition (TPN) in critical shortage will be imported into the United States and available to patients this week.
TPN is an intravenous"...
Neostigmine Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Neostigmine methylsulfate injection is used to treat myasthenia gravis, postoperative distention and urinary retention, and to reverse effects of non-depolarizing neuromuscular blocking agents after surgery. It is an anticholinesterase agent. Common side effects include salivation, muscle twitching, bowel cramps, or diarrhea.
Dosage of neostigmine methylsulfate injection depends on the condition being treated. Neostigmine methylsulfate injection may interact with muscle relaxants, antibiotics, local and some general anesthetics, or antiarrhythmics. Tell your doctor all medications and supplements you use. During pregnancy, neostigmine methylsulfate injection should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
Our neostigmine methylsulfate injection Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Neostigmine FDA Prescribing Information: Side Effects
The following additional adverse reactions have been reported following the use of either Neostigmine Bromide or Neostigmine Methylsulfate (neostigmine methylsulfate (neostigmine methylsulfate injection) injection) .
Allergic: Allergic reactions and anaphylaxis.
Cardiovascular: Cardiac arrhythmias (including bradycardia, tachycardia, A-V block and nodal rhythm) and nonspecific EKG changes have been reported, as well as cardiac arrest, syncope and hypotension.These have been predominantly noted following the use of the injectable form of Neostigmine Methylsulfate (neostigmine methylsulfate (neostigmine methylsulfate injection) injection) .
Genitourinary: Urinary frequency.
Miscellaneous: Diaphoresis, flushing and weakness.
Read the entire FDA prescribing information for Neostigmine (Neostigmine Methylsulfate Injection) »
Additional Neostigmine Methylsulfate Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.